Same Indication

Osimertinib vs Rosuvastatin

Osimertinib vs Rosuvastatin: Overview

This comparison examines the pharmacological differences between Osimertinib and Rosuvastatin.

Mechanism of Action

Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.

Rosuvastatin: Competitive inhibitor of HMG-CoA reductase.

Pharmacokinetics

Half-life: Osimertinib — 48 hours; Rosuvastatin — 19 hours.

Chemical Properties

Molecular Formula: Osimertinib — C28H33N7O2; Rosuvastatin — C22H28FN3O6S.

Molecular Weight: Osimertinib — 499.6050 g/mol; Rosuvastatin — 481.5390 g/mol.

Type: Osimertinib — Small molecule; Rosuvastatin — Small molecule.